MINNEAPOLIS, Dec. 22, 2020 (GLOBE NEWSWIRE) — Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the 39th Annual J.P. Morgan Healthcare Conference on Wednesday, January 13, 2021.
Inspire is scheduled to present at 3:40 p.m. Eastern Time. The presentation will be accessible via a live webcast at:
A webcast replay of the presentation will be available for two weeks following the presentation in the Event Archive section of Inspire’s Investor website at https://investors.inspiresleep.com.
About Inspire Medical Systems
Inspire is a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea. Inspire’s proprietary Inspire therapy is the first and only FDA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.
For additional information about Inspire, please visit www.inspiresleep.com.
Investor and Media Contact:
- TOP Ships Announces Pricing of $13.5 Million Public Offering - December 4, 2022
- TUESDAY INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Opendoor Technologies Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit – OPEN; OPENW - December 4, 2022
- OLPX EQUITY ALERT: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Olaplex Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – OLPX - December 4, 2022